SIG Brokerage’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.14M Buy
14,986
+13,510
+915% +$2.05M 0.03% 363
2026
Q2
$231K Buy
+1,476
New +$221K ﹤0.01% 822
2025
Q2
– Sell
-3,239
Closed -$361K – 822
2025
Q1
$361K Buy
+3,239
New +$345K 0.02% 407

Other funds holding NVS

SIG Brokerage's NVS Position: Q3 2026 in Review

SIG Brokerage increased its Novartis (NVS) stake by 915% in Q3 2026, buying an estimated $2.05M and bringing the position to 14,986 shares worth $2.14M. The position accounts for 0.03% of the portfolio, ranked #363.

SIG Brokerage first reported a position in NVS in Q1 2025 and has held it in 3 quarters since. 1,547 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • SIG Brokerage held 14,986 shares of Novartis worth $2.14M as of Q3 2026.
  • SIG Brokerage bought 13,510 Novartis shares in Q3 2026, an estimated $2.05M.
  • Novartis made up 0.03% of SIG Brokerage's portfolio in Q3 2026, its #363 holding.
  • SIG Brokerage first reported a position in Novartis in Q1 2025 and has held it in 3 quarters since.
  • 1,547 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on SIG Brokerage's 13F filing for Q3 2026, filed 16 Nov 2026.